The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preoperative durvalumab (D) with or without tremelimumab (T) for resectable head and neck squamous cell carcinoma (HNSCC): Updated results with high dimensional profiling of circulating immune cells.
 
Chang Gon Kim
No Relationships to Disclose
 
Min Hee Hong
Stock and Other Ownership Interests - GI biome; GI cell
Honoraria - AstraZeneca; AstraZeneca; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Merck; Roche; Yuhan
Research Funding - Yuhan
 
Da Hee Kim
No Relationships to Disclose
 
Sun Min Lim
No Relationships to Disclose
 
Brian Lee
No Relationships to Disclose
 
Yoon Ji Bang
No Relationships to Disclose
 
Se-Heon Kim
No Relationships to Disclose
 
Young Min Park
No Relationships to Disclose
 
Kyoung-Ho Pyo
No Relationships to Disclose
 
Jae Hwan Kim
No Relationships to Disclose
 
Heejung Park
No Relationships to Disclose
 
Goeun Park
No Relationships to Disclose
 
Inkyung Jung
No Relationships to Disclose
 
Seunghee Kim-Schulze
No Relationships to Disclose
 
Miriam Merad
No Relationships to Disclose
 
Byoung Chul Cho
Leadership - Interpark Bio; J Ints Bio
Stock and Other Ownership Interests - Bridgebio; Cyrus therapeutics; Gencurix; Interpark Bio; Kanaph Therapeutics; Theravance
Consulting or Advisory Role - AstraZeneca; Blueprint medicines; Boehringer Ingelheim; Bridgebio; Bristol-Myers Squibb; Cyrus therapeutics; Guardant Health; J INTS BIO; Janssen; Kanaph Therapeutics; Lilly; Medpacto; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche; Takeda; Yuhan
Research Funding - Abbvie; AstraZeneca; Bayer; Blueprint medicines; Champions Oncology; Dizal Pharma; Dong-A ST; GI Innovation; Interpark Bio; Janssen; Lilly; Medpacto; Mogam Biotechnology Research Institue; MSD; Novartis; Ono Pharmaceutical; Yuhan
Patents, Royalties, Other Intellectual Property - Champions Oncology
Other Relationship - DAAN Biotherapeutics
 
Hyun Je Kim
No Relationships to Disclose
 
Yoon Woo Koh
No Relationships to Disclose
 
Hye Ryun Kim
No Relationships to Disclose